Minimally Invasive, Single-Use Designs Benefits Surgeons and Patients
Packaged sterile and pre-assembled for single use, the CoLink Bone Graft Harvester is a minimally invasive bone graft device that harvests bone from various sites in the body, including the calcaneus, iliac crest, proximal tibia, distal tibia, and distal femur. It is intended to morselize cancellous bone for enhanced bone healing in fusion and fracture stabilization procedures.
Most bone graft harvesting systems currently on the market are re-used on multiple patients, requiring extensive cleaning and re-processing. In2Bones, through its innovative design engine, developed this pre-sterilized, single use system that mitigates risk of surgical site infections, providing an economical solution as well as added safety and convenience for surgeons and hospitals.
A second new product, sterile Tribio Backfill Plugs, are a unique solution to backfilling bone defects. Tribio is derived from a proprietary blend of bioactive materials consisting of collagen matrix mineralized with hydroxyapatite (HA), tri-calcium phosphate (TCP), and bioactive glass. This potent combination of osteopromotive materials are individually packaged and sized to fit the corresponding void left by the CoLink Bone Graft Harvester.
The Tribio plug forms an osteoconductive, sponge-like scaffold that rapidly absorbs surrounding blood and fluids to aid in new bone formation during the healing process. Tribio Backfill Plugs can be used on harvested sites in the calcaneus, distal tibia, and proximal tibia, among other uses.
“The combination of the new CoLink Bone Graft Harvester and Tribio Backfill Plugs enables surgeons to rapidly harvest autograft through a small incision, and provides patients with an innovative, bioactive implant solution to backfill the surgical void created during the index procedure,” says Jon Simon, Sr. Vice President of Marketing at In2Bones.
The device duo is typically used in conjunction with surgical fixation devices during bone fusion and fracture repair procedures.
“The launch of these two new products positions the entire In2Bones product portfolio for pull-through and increased growth,” says Simon.
For more information about In2Bones Global, Inc. extremity products, please visit www.In2Bones.com.
Headquartered in Memphis, Tennessee, In2Bones is a global designer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. For more information, visit www.in2bones.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management’s current view of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “will,” and other similar terms. The company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties impacting the business, including increased competition, technical obsolescence, regulatory issues, general economic conditions and other risks.
Jon Simon | Sr. Vice President of Marketing
6000 Poplar Ave, Suite 115 Memphis, TN 38119
O: 901.260.7931 • F: 844-712-6637
SOURCE: Business Wire, 5th November 2019